Using a 0 to 3 intensity scale (Fig. 5a), we discovered an increase of ACAA2 expression in lung carcinoid (P = 0.033) and SCLC (P = 0.034), relative to the non-NE, adenocarcinoma patient samples (Fig. 5b, c). This evidence concerns the gene ACAA2 and lung carcinoid tumor.